US Stock MarketDetailed Quotes

TNGX Tango Therapeutics

Watchlist

1.840
-0.060-3.16%

Close Mar 4 16:00 ET

1.840
0.0000.00%

Post 16:05 ET

198.92MMarket Cap-1.55P/E (TTM)

Tango Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tango Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 6.487M	--
--	2025/Q1	-- / 6.801M	--
--	2024/Q4	4.117M / 8.018M	--
--	2024/Q3	11.607M / 8.066M	--
--	2024/Q2	19.875M / 7.632M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 6.487M--

--2025/Q1-- / 6.801M--

--2024/Q44.117M / 8.018M--

--2024/Q311.607M / 8.066M--

--2024/Q219.875M / 7.632M--

Unlock Free Earnings Estimates

Open Account

Tango Therapeutics Earnings Reports

Tango Therapeutics | 10-K: FY2024 Annual Report

Feb 27 07:13 ET

Tango Therapeutics | 8-K: Tango Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 27 07:06 ET

Tango Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 07:47 ET

Tango Therapeutics | 8-K: Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

Nov 6, 2024 07:27 ET